Ovarian cancer outcomes: Predictors of early death

Gynecologic Oncology

Volumn 140, Issue 3, 2016, Pages 474-480

  Urban, Renata R ^a   He, Hao ^b   Alfonso, Raphael ^b   Hardesty, Melissa M ^c   Gray, Heidi J ^a   Goff, Barbara A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Alaska Women's Cancer Care   (United States)

Author keywords

Chemotherapy; Education; Ovarian cancer; Resource allocation; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; DATA BASE; DEATH; DEMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICARE; ONCOLOGIST; OVARY CARCINOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; AGE; CANCER REGISTRY; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MORTALITY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; PREMATURE MORTALITY; RISK FACTOR; SURVIVAL RATE; TIME FACTOR; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MORTALITY, PREMATURE; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84959535141     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.12.021     Document Type: Article

References (33)

1. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J. Clin. 65 2015 5 29
2. J.D. Wright, L. Chen, A.I. Tergas, and et al. Trends in relative survival for ovarian cancer from 1975 to 2011 Obstet. Gynecol. 125 2015 1345 1352
3. B.A. Goff Measuring ovarian cancer care: why are we still failing? Gynecol. Oncol. 1-2 2015
4. R.E. Bristow, J. Chang, A. Ziogas, and H. Anton-Culver Adherence to treatment guidelines for ovarian cancer as a measure of quality care Obstet. Gynecol. 121 2013 1226 1234
5. W.A. Cliby, M.A. Powell, N. Al-Hammadi, and et al. Ovarian cancer in the United States: contemporary patterns of care associated with improved survival Gynecol. Oncol. 136 2015 11 17
6. M.M. Thrall, H.J. Gray, R.G. Symons, N.S. Weiss, D.R. Flum, and B.A. Goff Trends in treatment of advanced epithelial ovarian cancer in the Medicare population Gynecol. Oncol. 122 2011 100 106
7. M.M. Thrall, B.A. Goff, R.G. Symons, D.R. Flum, and H.J. Gray Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly Obstet. Gynecol. 118 2011 537 547
8. J.S. Temel, J.A. Greer, A. Muzikansky, and et al. Early palliative care for patients with metastatic non-small-cell lung cancer N. Engl. J. Med. 363 2010 733 742
9. J.L. Warren, C.N. Klabunde, D. Schrag, P.B. Bach, and G.F. Riley Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med. Care 40 2002 IV-3 I18.
10. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J. Clin. Epidemiol. 45 1992 613 619
11. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J. Chronic. Dis. 40 1987 373 383
12. A.M. Reb Transforming the death sentence: elements of hope in women with advanced ovarian cancer Oncol. Nurs. Forum 34 2007 E70 E81
13. J.D. Wright, C.V. Ananth, J. Tsui, and et al. Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer Cancer 120 2014 1246 1254
14. R.E. Bristow, J. Chang, A. Ziogas, B. Campos, L.R. Chavez, and H. Anton-Culver Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines Obstet. Gynecol. 125 2015 833 842
15. J.K. Chan, D.S. Kapp, J.Y. Shin, and et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients Obstet. Gynecol. 109 2007 1342 1350
16. J.K. Chan, R. Urban, M.K. Cheung, and et al. Ovarian cancer in younger vs older women: a population-based analysis Br. J. Cancer 95 2006 1314 1320
17. R.S. Groen, D.M. Gershenson, and A.N. Fader Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all Gynecol. Oncol. 136 2015 373 383
18. L.M. Landrum, S. Blank, L.M. Chen, and et al. Comprehensive care in gynecologic oncology: the importance of palliative care Gynecol. Oncol. 137 2015 193 202
19. J.A. Dottino, W.A. Cliby, E.R. Myers, R.E. Bristow, and L.J. Havrilesky Improving NCCN guideline-adherent care for ovarian cancer: value of an intervention Gynecol. Oncol. 2015
20. J.C. Weeks, P.J. Catalano, A. Cronin, and et al. Patients' expectations about effects of chemotherapy for advanced cancer N. Engl. J. Med. 367 2012 1616 1625
21. J. Fauci, K. Schneider, C. Walters, and et al. The utilization of palliative care in gynecologic oncology patients near the end of life Gynecol. Oncol. 127 2012 175 179
22. A.A. Wright, L.A. Hatfield, C.C. Earle, and N.L. Keating End-of-life care for older patients with ovarian cancer is intensive despite high rates of hospice use J. Clin. Oncol. 32 2014 3534 3539
23. S.K. Lutgendorf, K. De Geest, D. Bender, and et al. Social influences on clinical outcomes of patients with ovarian cancer J. Clin. Oncol. 30 2012 2885 2890
24. A.A. Aizer, M.H. Chen, E.P. McCarthy, and et al. Marital status and survival in patients with cancer J. Clin. Oncol. 31 2013 3869 3876
25. V.L. Beesley, M.A. Price, P.M. Webb, and et al. Changes in supportive care needs after first-line treatment for ovarian cancer: identifying care priorities and risk factors for future unmet needs Psycho-Oncology 22 2013 1565 1571
26. Howlader N. NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute.Available from URL: http://seer.cancer.gov/csr/1975-2011/.
27. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J. Clin. Oncol. 20 2002 1248 1259
28. G.S. Cooper, B. Virnig, C.N. Klabunde, N. Schussler, J. Freeman, and J.L. Warren Use of SEER-Medicare data for measuring cancer surgery Med. Care 40 IV 2002 43 48
29. P.B. Bach, D. Schrag, and C.B. Begg Resurrecting treatment histories of dead patients: a study design that should be laid to rest J. Am. Med. Assoc. 292 2004 2765 2770
30. C.C. Earle, D. Schrag, B.A. Neville, and et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients J. Natl. Cancer Inst. 98 2006 172 180
31. C.N. Klabunde, J.L. Warren, and J.M. Legler Assessing comorbidity using claims data: an overview. Med. Care 40 IV- 2002 26 35
32. A.L. Potosky, J.L. Warren, E.R. Riedel, C.N. Klabunde, C.C. Earle, and C.B. Begg Measuring complications of cancer treatment using the SEER-Medicare data Med. Care 40 IV- 2002 62 68
33. U.S. Census Bureau. International database. Table 094. Midyear population, by age and sex. Available at http://www.census.gov/population/projections/.